Stop using now Drug recall · FDA · Published June 24, 2026

JB Chemicals Recalls Cetirizine Tablets Due to Cross-Contamination

JB Chemicals recalls 34,020 bottles of Cetirizine Hydrochloride Tablets due to Ranitidine cross-contamination. Check your lot numbers immediately.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0732-2026Drug JB Chemicals ›

Stop using this now

Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.

✎ GovInfoNow plain-language explainer

JB Chemicals and Pharmaceuticals Ltd is recalling 34,020 bottles of Cetirizine Hydrochloride Tablets USP 5 mg because they may be contaminated with Ranitidine. The recall was triggered by customer complaints regarding discolored tablets and red dots on the pills. This cross-contamination poses a Class I health hazard. Read more at govinfonow.com/recall/164252-jb-chemicals-recalls-cetirizine-tablets-due-to-cross-contamination.

Source Summary by GovInfoNow · govinfonow.com/recall/164252-jb-chemicals-recalls-cetirizine-tablets-due-to-cross-contamination · Updated October 9, 2026 · FDA enforcement record: FDA #D-0732-2026

Cite this page

“JB Chemicals Recalls Cetirizine Tablets Due to Cross-Contamination.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/164252-jb-chemicals-recalls-cetirizine-tablets-due-to-cross-contamination. Based on FDA recall #D-0732-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0732-2026%22&limit=1).

The FDA announced on June 24, 2026, that JB Chemicals and Pharmaceuticals Ltd is recalling Cetirizine Hydrochloride Tablets USP 5 mg due to potential cross-contamination with Ranitidine. The agency said the recall affects 34,020 bottles distributed nationwide.

How to tell if you have it

Brand: JB Chemicals
Product: Cetirizine Hydrochloride Tablets USP 5 mg
Packaging: 100-count bottle
Manufacturer: Unique Pharmaceuticals Labs
Distributor: Rising Pharma Holdings, Inc.
NDC: 16571-401-10
Lots: GY825029, GY825030, GY825031, GY825032
Expiration: 2028-OCT

The hazard

The FDA said customer complaints reported discolored tablets and red dots on the Cetirizine Hydrochloride Tablets USP 5 mg. Laboratory testing determined these contaminants to be Ranitidine.

Context

GovInfoNow's records show JB Chemicals has two other recalls since September 12, 2025, including an April 23, 2026 recall of Enalapril tablets for impurities and a September 12, 2025 recall of Cetirizine 10mg tablets for wrong ID imprint. Other recent recalls of similar products include Glenmark Bisoprolol/Hydrochlorothiazide Tablets Recall (November 21, 2025), Amerisource Health Primidone Tablets Recall (May 1, 2026), and Golden State Medical Supply Primidone Tablets Recall (April 27, 2026).

How to tell if you have this one

Check for a 100-count bottle of Cetirizine Hydrochloride Tablets USP 5 mg manufactured by Unique Pharmaceuticals Labs (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.) and distributed by Rising Pharma Holdings, Inc. Look for NDC 16571-401-10 and lot numbers GY825029, GY825030, GY825031, or GY825032.

Brand
JB Chemicals
Category
Drug

Based on the official FDA remedy

What to do — step by step

Stop taking the medication
Do not consume any tablets from the recalled lots due to the risk of Ranitidine contamination.
Check your lot numbers
Verify if your bottle has one of the following lot numbers: GY825029, GY825030, GY825031, or GY825032.
Contact the distributor
Reach out to Rising Pharma Holdings, Inc. for further instructions on returning or disposing of the product.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 35 days after the firm started it.

Jun 24, 2026Firm started the recall
Jul 29, 2026Published in FDA’s Enforcement Report
Aug 3, 2026FDA classified it Class I
Aug 11, 2026Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

What is the expiration date of the recalled bottles?

The recall record states the expiration date as 2028-OCT for the affected lots.

Similar recalls

Other JB Chemicals recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/164252-jb-chemicals-recalls-cetirizine-tablets-due-to-cross-contamination">JB Chemicals Recalls Cetirizine Tablets Due to Cross-Contamination (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0732-2026 (June 24, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0732-2026 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.